510(k) device
Aventus Thrombectomy System
Inquis Medical · Peripheral Mechanical Thrombectomy With Aspiration (QEW, Class II) · First FDA decision Nov 1, 2023, newest Jun 13, 2025Peripheral artery diseasePulmonary embolism and deep vein thrombosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
1
Naming "Aventus"
MAUDE reports
1
Brand "Aventus", since 2015
PubMed studies
1
Mentioning "Aventus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Aventus Thrombectomy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 5 decisions filed under this name.
K251189 · Decided Jun 13, 2025 · 57 days after receipt
Device type: Peripheral Mechanical Thrombectomy With Aspiration (QEW) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Aventus", any status and sponsor, newest update first.
- Aventus Thrombectomy System Pulmonary Embolism Clinical StudyActive, not recruiting
Inquis Medical, Inc.Not on our public-company list
NCT05907564 · 120 participants · Start Sep 20, 2023 · Primary completion Feb 20, 2025
Device: Thrombectomy · For: Pulmonary Embolism; Embolism; Embolism and Thrombosis and 4 more
Sites: Scottsdale, Arizona; Fairfield, California; Long Beach, California · 26 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Aventus", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code QEW
1,362 reports: 911 malfunction, 315 injury, 133 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Aventus"[tiab]. The summary above synthesizes these.
- Novel Aspiration Thrombectomy and Blood Reinfusion System for Acute Intermediate-Risk Pulmonary Embolism: AVENTUS Trial Results.
Sabri S, Horr S, Stegman B, et al. · J Soc Cardiovasc Angiogr Interv · 2025
Other devices of this type
Also filed under product code QEW.
- INDIGO® Aspiration SystemPenumbra, Inc. · 510(k) 2026
- FlowTriever Retrieval/Aspiration SystemInari Medical, Inc. · 510(k) 2021
- ClotTriever SheathInari Medical, Inc. · 510(k) 2023
- CAPERE Thrombectomy SystemVascular Medcure, Inc. · 510(k) 2020
- WOLF Thrombectomy SmartClaw CatheterDevoro Medical, Inc. · 510(k) 2022
- Protrieve SheathInari Medical · 510(k) 2025
- Pounce Thrombectomy SystemSurmodics,Inc. · 510(k) 2023
- Penumbra Embolectomy Aspiration System (INDIGOTM Aspiration System)Penumbra, Inc. · 510(k) 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.